![Wired.com](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/378/normal/Screen_Shot_2015-07-22_at_11.20.18.png?1437560443)
How a Medication for OCD Ended Up in a Covid-19 Trial
Wired.com,
Esther Landhui s 11.19.2020 07:00 AM In a small study, the drug kept patients with mild symptoms from worsening.
Esther Landhui s 11.19.2020 07:00 AM In a small study, the drug kept patients with mild symptoms from worsening.
. Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of…
. The Evolution of the Sigma-2 (σ2) Receptor from Obscure Binding Site to Bona Fide Therapeutic Target.
Mavlyutov TA, Baker EM, Losenegger TM, Kim JR, Torres B, Epstein ML, Ruoho AE.